ES2168521T3 - Anticuerpo monoclonal frente al complejo de factor xa-inhibidor de la via del factor tisular, y su uso. - Google Patents

Anticuerpo monoclonal frente al complejo de factor xa-inhibidor de la via del factor tisular, y su uso.

Info

Publication number
ES2168521T3
ES2168521T3 ES96943313T ES96943313T ES2168521T3 ES 2168521 T3 ES2168521 T3 ES 2168521T3 ES 96943313 T ES96943313 T ES 96943313T ES 96943313 T ES96943313 T ES 96943313T ES 2168521 T3 ES2168521 T3 ES 2168521T3
Authority
ES
Spain
Prior art keywords
factor
inhibitor
tissular
monoclonal antibody
antibody against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96943313T
Other languages
English (en)
Inventor
Isao Kohno
Yumiko Itoh
Kosuke Kumeta
Yuichi Kamikubo
Gilbu Soe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Iatron Laboratories Inc
Mitsubishi Kagaku Iatron Inc
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Iatron Laboratories Inc
Mitsubishi Kagaku Iatron Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken, Iatron Laboratories Inc, Mitsubishi Kagaku Iatron Inc filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Application granted granted Critical
Publication of ES2168521T3 publication Critical patent/ES2168521T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/02—Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • G01N2333/8114—Kunitz type inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96444—Factor X (3.4.21.6)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

UN ANTICUERPO MONOCLONAL QUE REACCIONA CON EL COMPLEJO INHIBIDOR DE LA VIA DEL FACTOR TISULAR ON ESPECIFICIDAD, PERO QUE NO REACCIONA CON EL FACTOR X, FACTOR XA LIBRE E INHIBIDOR DE LA VIA DEL FACTOR TISULAR (TFPI), UN HIBRIDOMA QUE SECRETA EL ANTICUERPO MONOCLONAL Y UN METODO PARA MEDIR INMUNOLOGICAMENTE XA TICUERPO MONOCLONAL.
ES96943313T 1995-12-26 1996-12-26 Anticuerpo monoclonal frente al complejo de factor xa-inhibidor de la via del factor tisular, y su uso. Expired - Lifetime ES2168521T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33922995A JP3681206B2 (ja) 1995-12-26 1995-12-26 抗ファクターＸａ・ティシュファクターパスウェイインヒビター複合体モノクローナル抗体及びその使用

Publications (1)

Publication Number Publication Date
ES2168521T3 true ES2168521T3 (es) 2002-06-16

Family

ID=18325482

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96943313T Expired - Lifetime ES2168521T3 (es) 1995-12-26 1996-12-26 Anticuerpo monoclonal frente al complejo de factor xa-inhibidor de la via del factor tisular, y su uso.

Country Status (7)

Country Link
EP (1) EP0812859B1 (es)
JP (1) JP3681206B2 (es)
KR (1) KR100249314B1 (es)
AU (1) AU706547B2 (es)
DE (1) DE69619226T2 (es)
ES (1) ES2168521T3 (es)
WO (1) WO1997023509A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002316999A (ja) * 2001-04-17 2002-10-31 Dai Ichi Pure Chem Co Ltd モノクローナル抗体
UA112050C2 (uk) * 2008-08-04 2016-07-25 БАЄР ХЕЛСКЕР ЛЛСі Терапевтична композиція, що містить моноклональне антитіло проти інгібітора шляху тканинного фактора (tfpi)
KR101977846B1 (ko) 2008-12-19 2019-05-14 박스알타 인코퍼레이티드 Tfpi 억제제 및 사용 방법
CN102325795B (zh) 2008-12-22 2015-03-25 诺沃—诺迪斯克有限公司 针对组织因子途径抑制剂的抗体
EP3708190A1 (en) * 2010-02-26 2020-09-16 Novo Nordisk A/S Stable antibody containing compositions
NZ602115A (en) * 2010-03-01 2014-12-24 Bayer Healthcare Llc Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
JP5730983B2 (ja) 2010-03-19 2015-06-10 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ Ｔｆｐｉ阻害剤および使用方法
US20130136733A1 (en) 2010-05-28 2013-05-30 Novo Nordisk A/S Stable Multi-Dose Compositions Comprising an Antibody and a Preservative
NZ629130A (en) 2012-03-21 2016-10-28 Baxalta Inc Tfpi inhibitors and methods of use
WO2016157513A1 (ja) * 2015-04-03 2016-10-06 株式会社日立製作所 抗原抗体間相互作用量の同定法及び装置

Also Published As

Publication number Publication date
JP3681206B2 (ja) 2005-08-10
JPH09176199A (ja) 1997-07-08
KR19980702438A (ko) 1998-07-15
KR100249314B1 (ko) 2000-03-15
DE69619226T2 (de) 2002-08-14
WO1997023509A1 (fr) 1997-07-03
EP0812859A1 (en) 1997-12-17
DE69619226D1 (de) 2002-03-21
EP0812859A4 (en) 2000-04-26
AU706547B2 (en) 1999-06-17
AU1208997A (en) 1997-07-17
EP0812859B1 (en) 2002-02-13

Similar Documents

Publication Publication Date Title
KR940015780A (ko) 터치 태블릿 (touch tablet) 이 달린 데이타 입력 장치
FR2705785B1 (fr) Procédé pour déterminer la fonction d'atténuation d'un objet par rapport à la transmission d'une épaisseur de référence d'un matériau de référence et dispositif pour la mise en Óoeuvre du procédé.
TW324772B (en) The latex-band and method for repairing piping
DE69431540D1 (de) Abdichtung für Gasturbinen
DE69416277T2 (de) Kühlungssystem für Gasturbinenleitschaufel
ES2168521T3 (es) Anticuerpo monoclonal frente al complejo de factor xa-inhibidor de la via del factor tisular, y su uso.
DE69427640D1 (de) Mit Sprachausgabe ausgestattetes Prüfgerät FÜR COMPUTERGESTEUERTE GERÄTE
TW358795B (en) Passenger conveying device, balustrade for a passenger conveying device, and balustrade outer decking
DE69204169D1 (de) Triebwerkanordnung für gasturbinen.
DE69610200D1 (de) Opto-elektronischer messapparat für die verifikation von lineardimensionen
DE69409170D1 (de) Messvorrichtung für Hochdruckgas
EP0902286A3 (en) Immunoassay utilizing two incubations with labelled antigen
ES2115022T3 (es) Inmunoensayo de isotiazolonas.
ES2102858T3 (es) Procedimiento que utiliza electroquimioluminiscencia.
DE59308231D1 (de) Vakuum-lecksuchgerät für die testgaslecksuche mit leichten gasen
DE68910110T2 (de) Entladungsrohr für gaslaseranordnung.
AU7896891A (en) Trypsin inhibitor (alpha, at) peptide, immunoassay, monoclonal antibody and hybridoma
ES2019573T3 (es) Inmunoensayo para la deteccion de alfa-haloacetamidas.
ES2110902A1 (es) Dispositivo de fijacion de la escala en una regla optica.
DE29511691U1 (de) Flexible Hauseinführung, insbesondere für eine Gasleitung
DE69923708D1 (de) Nachweisverfahren für microthrix parvicella
DE59209044D1 (de) Gasbrenner, insbesondere für flüssiggas
HUP9701386A2 (hu) Immunológiai vizsgálati eljárás
DK0964875T3 (da) Antistof specifikt for 5-hydroxytryptophol eller et konjugat deraf samt immunoassay til bestemmelse af 5-hydroxytryptophol eller konjugater deraf
DE69502099D1 (de) Paracetamolphosphat für immunoassays

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 812859

Country of ref document: ES